Tetra Bio-Pharma sells rights to non-opioid candidate
Alpha Blue Ocean (“ABO”) Announces a CAD 10M Financing Arrangement with Tetra Bio-Pharma (“TBP” or the “Company”) | Business Wire
IntelGenx and Tetra Bio-Pharma developing dronabinol tablet
Tetra Bio-Pharma - Home | Facebook
Tetra Bio-Pharma Announces Start of the REBORN1(C) Clinical Trial - Tetra Bio-Pharma
Tetra Bio-Pharma and Cellvera to develop ARDS-003 in combination with favipiravir for COVID-19 | BioWorld
Tetra Bio-Pharma | LinkedIn
Tetra Bio-Pharma Strengthens Management Team
Tetra Bio-Pharma on Twitter: "1/ ‼️ #BREAKING We are excited to announce a #research and development agreement with Cannvalate for the initiation of the REBORN®, PLENITUDE® and CAUMZ® #clinicaltrials in #Australia 🇦🇺. $
Tetra Bio-Pharma announces acquisition of IP to develop natural health products through its Agro-Tek subsidiary
Tetra Bio-Pharma Appoints Chief Financial Officer
Tetra Bio-Pharma reports results from trial of ARDS-003 and Favipiravir
2020 could be a breakout year for Tetra Bio-Pharma, says Paradigm Capital - Cantech Letter
Innovation and drug development with Tetra Bio-Pharma
Investors - Governance - Executive Management - Tetra Bio-Pharma
Tetra Bio-Pharma Engages Christine Caron as Patient Partner - Tetra Bio- Pharma
TETRA BIO-PHARMA INC. MANAGEMENT'S DISCUSSION AND ANALYSIS
Tetra Bio Pharma Inc. | CSE - Bourse des valeurs canadiennes
UNB announces cannabis health research chair
Tetra Bio-Pharma
Tetra Bio-Pharma Appoints Chief Financial Officer - PharmTech Focus
Tetra Bio-Pharma (@TetraBioPharma) / Twitter
Tetra Bio-Pharma on Twitter: "Tetra Bio-Pharma is an authentic 🇨🇦 biopharmaceutical company leading transformational change in identifying and commercializing new molecular entities for #pain and #inflammation. $TBP $TBPMF #cannabinoids ...
Tetra Bio-Pharma
Tetra Bio-Pharma Announces Stock Option Grant | AP News
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
Akanda to Supply Tetra Bio-Pharma with Pharmaceutical-Grade Cannabis for FDA Trials of QIXLEEF™, a Potential Multimillion Dollar Prescription Drug
